Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Soler-Botija, C.
Right arrow Articles by Tizzano, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soler-Botija, C.
Right arrow Articles by Tizzano, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 125, No. 7, 1624-1634, July 2002
© 2002 Guarantors of Brain

Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord

Caroline Soler-Botija1, Isidre Ferrer2, Ignasi Gich3, Montserrat Baiget1 and Eduardo F. Tizzano1

1 Servei de Genètica and Institut de Recerca, 3 Servei d’Epidemiologia Clínica, Hospital de Sant Pau, Barcelona, 2 Institut de Neuropatologia, Departament de Biologia Cellular i Anatomia Patològica, Bellvitge, Universitat de Barcelona, Campus de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain

Correspondence to: E. F. Tizzano, Genetics and Research Institute, Hospital of Sant Pau, Av. Sant Antoni Ma Claret 167, 08025 Barcelona, Spain E-mail: etizzano{at}hsp.santpau.es

Spinal muscular atrophy (SMA) is an autosomal recessive disorder caused by mutations in the survival motor neurone gene (SMN). The degeneration and loss of the anterior horn cells is the major neuropathological finding in SMA, but the mechanism and timing of this abnormal motor neurone death remain unknown. A quantitative study was carried out comparing neuronal death in controls and SMA foetuses and neonates. Between 12 and 15 weeks of gestational age, a significant increase in nuclear DNA vulnerability, as revealed with the method of in situ end-labelling of nuclear DNA fragmentation, was detected in SMA foetuses and was reflected by a decrease in the number of neurones of the anterior horn. Neurones with nuclear DNA vulnerability are no longer detected at the end of the foetal period and the post-natal period. On the other hand, abnormal morphology of motor neurones, mainly early chromatolytic changes, was observed only after birth. Our findings indicate that in type I SMA, the absence or dysfunction of SMN is reflected by an enhanced neuronal death that is already detectable at 12 weeks, the earliest SMA foetal stage analysed. This is associated with a progressive loss of motor neurones towards the neonatal period. Given that a proportion of the remaining SMA motor neurones in the neonatal period appear with pathological findings not detected at earlier stages, it can be hypothesized that type I SMA results in differential age-dependent responses leading to cell death and motor neurone degeneration during development.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
H. Tadesse, J. Deschenes-Furry, S. Boisvenue, and J. Cote
KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy
Hum. Mol. Genet., February 14, 2008; 17(4): 506 - 524.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Botta, A. Tacconelli, I. Bagni, E. Giardina, E. Bonifazi, A. Pietropolli, M. Clementi, and G. Novelli
Transmission ratio distortion in the spinal muscular atrophy locus: Data from 314 prenatal tests
Neurology, November 22, 2005; 65(10): 1631 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J.-C. Lesbordes, C. Cifuentes-Diaz, A. Miroglio, V. Joshi, T. Bordet, A. Kahn, and J. Melki
Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy
Hum. Mol. Genet., June 1, 2003; 12(11): 1233 - 1239.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.